Kimia Biosciences Limited (BOM:530313)

Kimia Biosciences Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	1,259	1,189	1,049	1,285	1,249	1,327
Revenue	1,259	1,189	1,049	1,285	1,249	1,327
Revenue Growth (YoY)	17.66%	13.39%	-18.39%	2.89%	-5.89%	24.86%
Cost of Revenue	793.54	722.18	765.16	977.05	934.67	979.44
Gross Profit	465.72	467.03	283.6	308.11	314.34	347.7
Selling, General & Admin	146.18	149.86	167.71	181.01	158.49	154.72
Other Operating Expenses	137.32	114.68	112.6	156.53	149.35	109.2
Operating Expenses	319.51	298.32	313.23	370.86	337.25	283.02
Operating Income	146.21	168.71	-29.63	-62.75	-22.91	64.68
Interest Expense	-33.99	-35.33	-44.46	-37.41	-31.01	-24.79
Interest & Investment Income	0.22	0.22	0.37	0.29	0.31	0.54
Currency Exchange Gain (Loss)	5.89	5.89	-0.75	-14.54	2.41	13.09
Other Non Operating Income (Expenses)	-2.54	-3.15	-0.99	0.25	0.21	1.02
EBT Excluding Unusual Items	115.79	136.34	-75.46	-114.16	-50.99	54.55
Gain (Loss) on Sale of Investments	-	-	0	0.03	0.02	0.41
Gain (Loss) on Sale of Assets	-	-	-	-	0.79	0.37
Other Unusual Items	-	-	3.62	-9.75	-	0.02
Pretax Income	115.79	136.34	-71.84	-123.88	-50.18	55.34
Income Tax Expense	33.98	40.22	-18.75	-30.36	-13.15	4.3
Net Income	81.81	96.12	-53.09	-93.52	-37.03	51.04
Net Income to Common	81.81	96.12	-53.09	-93.52	-37.03	51.04
Net Income Growth	182.70%	-	-	-	-	269.56%
Shares Outstanding (Basic)	47	47	47	47	47	47
Shares Outstanding (Diluted)	47	47	47	47	47	47
Shares Change (YoY)	-0.64%	-	-	-	-	-
EPS (Basic)	1.73	2.03	-1.12	-1.98	-0.78	1.08
EPS (Diluted)	1.73	2.03	-1.12	-1.98	-0.78	1.08
EPS Growth	184.25%	-	-	-	-	280.93%
Free Cash Flow	80.61	167.15	130.28	-95.82	44.17	-75.94
Free Cash Flow Per Share	1.70	3.53	2.75	-2.02	0.93	-1.60
Gross Margin	36.98%	39.27%	27.04%	23.97%	25.17%	26.20%
Operating Margin	11.61%	14.19%	-2.83%	-4.88%	-1.83%	4.87%
Profit Margin	6.50%	8.08%	-5.06%	-7.28%	-2.96%	3.85%
Free Cash Flow Margin	6.40%	14.06%	12.42%	-7.46%	3.54%	-5.72%
EBITDA	180.58	200.85	2.72	-30.03	6.05	83.29
EBITDA Margin	14.34%	16.89%	0.26%	-2.34%	0.48%	6.28%
D&A For EBITDA	34.37	32.14	32.35	32.73	28.96	18.61
EBIT	146.21	168.71	-29.63	-62.75	-22.91	64.68
EBIT Margin	11.61%	14.19%	-2.83%	-4.88%	-1.83%	4.87%
Effective Tax Rate	29.35%	29.50%	-	-	-	7.77%
Revenue as Reported	1,273	1,202	1,065	1,297	1,258	1,352
Advertising Expenses	-	9.62	12.43	14.13	5.29	11.53

Source: S&P Global Market Intelligence. Standard template. Financial Sources.